Chugai Licenses RAF-MEK Molecular Glue SPYK04 to InxMed
Chugai Pharmaceutical grants InxMed an exclusive worldwide licence for SPYK04, a RAF-MEK molecular glue being developed for solid tumours.
InxMed | 30/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy